Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Drug Research
Drug Delivery
Return to: PBR Home | Drug Research | Drug Delivery

Drug Delivery

Oxford BioDynamics participates in rheumatoid arthritis triggers study Oxford BioDynamics is participating in a collaboration to identify the biological factors that trigger disease relapses, known as flares, in Rheumatoid Arthritis (RA), entitled the BIO-FLARE study (Biological factors that limit sustained remission in Rheumatoid Arthritis).
Drug Research > Drug Delivery > News
UK's MHRA grants early access to Sanofi’s dermatology treatment The UK's Medicines and Healthcare Products Regulatory Agency (MHRA) has granted Sanofi’s dupilumab, an investigational treatment for atopic dermatitis (AD), a positive scientific opinion through the Early Access to Medicines Scheme (EAMS).
Drug Research > Drug Delivery > News Pfizer launches Zavicefta in UK and Germany Pfizer has launched Zavicefta (ceftazidime/avibactam), a combination antibiotic to treat Gram-negative bacterial infections requiring hospitalization, in the UK and Germany.
Drug Research > Drug Delivery > News
See more Drug Delivery news

Latest Drug Delivery News and Insight

View all Drug Delivery news or find news targeted to your interests
New Vetter Data Processing Center is Officially Certified
IT experts of TÜV Süd, a German industrial testing organization, have certified the new data processing center at Vetter's headquarters in Ravensburg, Germany. The pharmaceutical service provider has fulfilled all requirements to meet the "TÜV Süd certified data processing center" criteria.
Drug Research > Drug Delivery > Press Releases
Vetter's Skokie Site Successfully Manufactures Batches on New Clinical Syringe Filling Line
Vetter, a leading international contract development and manufacturing organization (CDMO) that specializes in aseptic filling for its (bio-)pharmaceutical customers, has announced today that its new clinical syringe line has already manufactured for its customers a double digit number of batches for use in early clinical trials.
Drug Research > Drug Delivery > Press Releases
Vetter Starts Operations in its Center for Visual Inspection and Logistics
Vetter, a leading global Contract Development and Manufacturing Organization (CDMO) for development, aseptic filling and final packaging of injectables, has announced today that it has begun operations in its expanded Visual Inspection and Logistics Center located in Ravensburg.
Drug Research > Drug Delivery > Press Releases
Lilly's Trulicity label updated to include use in combination with basal insulin for type 2 diabetes
Eli Lilly and Company has updated label of its once-weekly Trulicity (dulaglutide) to include use in combination with basal insulin for adults with Type 2 diabetes.
Drug Research > Drug Delivery > News
US FTC sues Shire ViroPharma for delaying generic entry of Vancocin
By PBR Staff Writer
The US Federal Trade Commission (FTC) has charged that Shire ViroPharma abused government processes via serial, sham petitioning to delay generics and maintain its monopoly over Vancocin HCl Capsules.
Drug Research > Drug Delivery > News
Soligenix's SGX301 secures PIM status from UK MHRA to treat cutaneous T-cell lymphoma
Soligenix has secured Promising Innovative Medicine (PIM) designation from the UK Medicines and Healthcare Products Regulatory Agency for SGX301 (synthetic hypericin) to treat cutaneous T-cell lymphoma (CTCL).
Drug Research > Drug Delivery > News
View all Drug Delivery news or find news targeted to your interests